• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERAII BRONCHOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERAII BRONCHOVIDEOSCOPE Back to Search Results
Model Number BF-1T180
Device Problems Biofilm coating in Device (1062); Loose or Intermittent Connection (1371)
Patient Problems Bacterial Infection (1735); No Known Impact Or Consequence To Patient (2692)
Event Type  Injury  
Manufacturer Narrative
The scope was returned to the service center however the investigation is ongoing.A review of the service history of the scope indicates the scope was purchased on (b)(6) 2009 and there are four repairs in the past three years.The last repair involved a loose biopsy port.In addition, an endoscopy support specialist (ess) was requested to be dispatched to the user facility to observe the facility¿s reprocessing practice and to provide a reprocessing training.To date, the ess visit has not been finalized.If additional information becomes available, this report will be supplemented accordingly.
 
Event Description
The service center was informed that the scope's biopsy port was noted to be loose.The biopsy port was reportedly taken apart and foreign residue was present.There was no patient injury reported, however, the user facility reported the scope was linked to two cases of possible contamination.This is for 2 of 2 reports.
 
Event Description
The service center was informed by the clinical nurse manager at the user facility further reported that were was a possible contamination issue as three different patients that had undergone bronchoscopy (with navigation) procedures were cultured via aerobic culture and gram stain broncho alveolar lavagepositive and were positive for a "light" growth of serratia marcescensgram.It was reported one scope was involved.Additionally, the user facility reported the biopsy port at the proximal end of the scope was noted to be loose.The biopsy port was reportedly taken apart and foreign residue was present.The user facility had not cultured the referenced scope and the scope was returned to the service center for evaluation.The clinical nurse believes contamination of specimen was the cause of the patients' outcomes.This report is for patient# 2.
 
Manufacturer Narrative
Regarding the reprocessing, the scope is pre-cleaned immediately following navigation procedure.Then scope is stored in a clean cabinet until ready to perform navigation.The endoscope is leak tested prior to manual cleaning and the endoscope channel is brushed during manual cleaning.The cleaning/disinfectant solution's minimum effective concentration are checked every wash cycle.There has not been any problem noted with the automated endoscope reprocessor (aer)machine.There is no manual flushing of air into the channel of the endoscope after reprocessing as the aer machine flushes air at the end of the cycle.The last time a reprocessing in-service reprocessing was provided was september 2018.There has been changes to the reprocessing personnel since then.All of the reprocessing personnel have been properly trained on how to reprocess an endoscope.The scope is stored in a self-ventilated/clean scope cabinet.An endoscopy support specialist (ess) visited the user facility on december 5, 2019 and performed a cleaning in-service with the staff.In-services included all the cleaning and disinfecting information contained in the olympus manual.An observation of facility's reprocessing practice was not performed.However, the ess did emphasize to the staff to always check that the biopsy port is intact and not loose prior to use.The scope was returned to the service center and was forwarded to an independent laboratory for microbial testing; results are pending.The cause of the reported event cannot be determined as the investigation is ongoing.If additional information becomes available, this report will be supplemented accordingly.Please reference the related internal complaints, importer mfr report numbers.((b)(6) / patient 1 2951238-2019-03710, ((b)(6) / patient 2) 2951238-2019-01225 and ((b)(6) / patient 3) 2951238-2019-01219.
 
Manufacturer Narrative
The scope was sent to an independent laboratory for microbial testing.The scope's instrument/suction channel tested positive for serratia marcescens.The scope was ethylene oxide (eto) sterilized and returned to the service center for a physical evaluation.A visual inspection was performed on the scope's instrument and suction channels.Scratch marks were noted inside the instrument channel from the biopsy port side.There were kinks observed inside the instrument channel from the distal bending section side.There was no evidence of foreign material or residue inside the channel or at the biopsy port.The scope passed the leak test.The service group noted the biopsy port was loose and the bending section was dented.In addition, the glue inside the channel at the distal end cover side was peeling.The scope was repaired and returned to the user facility.Based on the investigation, the cause of the reported positive patient and scope cultures could not be conclusively determined.However, the clinical nurse manager reported pre-cleaning is not performed immediately after a procedure, as the physician uses scope for airway evaluation, then scope is stored in a clean cabinet until ready to perform navigation.The scope is pre-cleaned immediately following navigation procedure.As a preventive measure, the reprocessing manual provides warning and cautions that states, if the endoscope is not immediately cleaned after each procedure, residual organic debris will begin to solidify and it may be difficult to effectively reprocess the endoscope.All channels of the endoscope must be cleaned and high-level disinfected or sterilized during every reprocessing cycle, even if the channels were not used during the previous patient procedure.Otherwise, insufficient cleaning and disinfection or sterilization of the endoscope may pose an infection control risk to the patient and/or operators performing the next procedure with the endoscope.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERAII BRONCHOVIDEOSCOPE
Type of Device
BRONCHOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key9238618
MDR Text Key202877884
Report Number8010047-2019-03711
Device Sequence Number1
Product Code EOQ
Combination Product (y/n)N
PMA/PMN Number
K061313
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 01/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberBF-1T180
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/02/2019
Was the Report Sent to FDA? No
Date Manufacturer Received01/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
70% ISOPROPYL ALCOHOL.; AER: OER PRO S/N (B)(6) AND (B)(6).; FIRST STEP-PRE CLEANING KIT ENZYMATIC DETERGENT.; MEDIVATOR CHANNEL CLEANING BRUSH#100402.; MEDIVATOR/VERISCAN LEAK TESTER.; OLYMPUS ACECIDE-C.; OLYMPUS ENDOQUICK-ALKALINE DETERGENT.; TERGAL 800 DETERGENT.
Patient Age77 YR
Patient Weight97
-
-